28th Nov 2017 16:25
NMC Health plc
PDMR notification
London, 28 November 2017: NMC Health plc (LSE:NMC) ('NMC'), the leading integrated private healthcare network operator in the GCC and one of the leading global providers of fertility treatments through its European, South American and Middle Eastern subsidiaries, announces that it received notification on 27 November 2017 from Jonathan Bomford, an Independent Non-Executive Director of the Company, that on 27 November 2017 he sold a total of 3,000 ordinary shares of 10p each in the Company ("Shares") at an average price of 2,875.00 pence per share, and further bought, through his SIPP, 2,000 ordinary shares of 10p each in the Company ("Shares") at an average price of 2,876.55 pence per share. In addition, Mr Bomford's spouse, Marion Bomford, bought through her SIPP, 1,000 ordinary shares of 10p each in the Company ("Shares") at an average price of 2,876.88 pence per share.
Following this transaction, Jonathan Bomford's share interest remains at a total of 18,000 Shares, representing approximately 0.01% of the issued share capital of the Company, including Mrs Marion Bomford's direct interest in the shares of the company, totalling 4,000 shares.
The Notification of Dealing Form for both Jonathan Bomford & Mrs Marion Bomford can be found below.
This notification is made in accordance with the Market Abuse Regulation.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||||||||||
a) | Name | Jonathan Bomford & Marion Bomford | ||||||||||||
2 | Reason for the notification | |||||||||||||
a) | Position/status | Independent Non-Executive Director of NMC Health plc & Spouse | ||||||||||||
b)
| Initial notification /Amendment | Initial notification | ||||||||||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||||||
a) | Name | NMC Health plc | ||||||||||||
b) | LEI | 2138008YQEVWBE1V2M52
| ||||||||||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||||||
a)
| Description of the financial instrument, type of instrument Identification code | Ordinary Shares
ISIN: GB00B7FC0762 | ||||||||||||
b) | Nature of the transaction | Jonathan Bomford: Purchase & Sale of shares; Purchase of shares made through SIPP
Marion Bomford: Purchase of shares made through SIPP | ||||||||||||
c) | Jonathan Bomford: SALE Price(s) and volume(s)
PURCHASE Price(s) and volume(s) Marion Bomford: Price(s) and volume(s) |
| ||||||||||||
d) | Jonathan Bomford: Aggregated information - volume - Price - Total Marion Bomford: Aggregated information - volume - Price - Total | SHARE SALE SHARE PURCHASE
[3000] [2000]
[2875.00] pence [2876.55] pence
£86,250 £57,531
1000
[2876.88] pence
£28,768.80 | ||||||||||||
e) | Date of the transaction | 27 November 2017 | ||||||||||||
f) | Place of the transaction | London Stock Exchange | ||||||||||||
Contacts
Investors |
|
NMC |
|
Simon Watkins, Group Company Secretary | +44 (0)20 3205 7313 |
|
|
|
|
Media |
|
FTI Consulting, London | +44 (0)20 3727 1000 |
Brett Pollard |
|
|
|
FTI Consulting, Gulf |
|
Shane Dolan | +971 (0)4 437 2100 |
Related Shares:
NMC.L